Llanos, Susana

Identification and characterization of Cardiac Glycosides as senolytic compounds

Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 384

A versatile drug delivery system targeting senescent cells

Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., et al. (2018) · EMBO Molecular Medicine

Telomeres, Telomerase, and SenescenceNanoparticle-Based Drug Delivery

Cited by 339

INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence

Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 220

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Chaib, S., López-Domínguez, J. A., Lalinde-Gutiérrez, M., Prats, N., Marin, I., Boix, O., García-Garijo, A., Meyer, K., Muñoz, M. I., Aguilera, M., et al. (2024) · Nature Cancer

Telomeres, Telomerase, and SenescenceCancer Immunotherapy and Biomarkers

Cited by 114

Lysosomal trapping of palbociclib and its functional implications

Llanos, S., Megias, D., Blanco-Aparicio, C., Hernández-Encinas, E., Rovira, M., Pietrocola, F., & Serrano, M. (2019) · Oncogene

Advanced Breast Cancer TherapiesNanoparticle-Based Drug Delivery

Cited by 96

Absence of p16 INK4a and truncation of ARF tumor suppressors in chickens

Kim, S.-H., Mitchell, M., Fujii, H., Llanos, S., & Peters, G. (2003) · Proceedings of the National Academy of Sciences

Cancer-related Molecular PathwaysTelomeres, Telomerase, and Senescence

Cited by 63